Cargando…

Clinical Effectiveness of Oncological Treatment in Metastatic Colorectal Cancer Is Independent of Comorbidities and Age

SIMPLE SUMMARY: Colorectal cancer (CRC) is the third most common cancer worldwide. As with many other cancers, the risk for CRC increases with age. This is also true for comorbidities, which may hamper sufficient treatment of the cancer. Due to restrictive inclusion criteria, older patients and pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niedersüß-Beke, Dora, Orlinger, Manuel, Falch, David, Heiler, Cordula, Piringer, Gudrun, Thaler, Josef, Hilbe, Wolfgang, Petzer, Andreas, Rumpold, Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123394/ https://www.ncbi.nlm.nih.gov/pubmed/33925931 http://dx.doi.org/10.3390/cancers13092091

Ejemplares similares

Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis
por: Rumpold, Holger, et al.
Publicado: (2020)

Current concepts of anti-EGFR targeting in metastatic colorectal cancer
por: Doleschal, Bernhard, et al.
Publicado: (2022)

Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment
por: Doleschal, Bernhard, et al.
Publicado: (2023)

Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 Therapy
por: Huemer, Florian, et al.
Publicado: (2020)

Influence of a Structured Exercise Training on Patients Reported Quality of Life in Colorectal Cancer Patients After Adjuvant Chemotherapy: A Pilot Study
por: Piringer, Gudrun, et al.
Publicado: (2020)

Ongoing complete response after treatment cessation with dabrafenib, trametinib, and cetuximab as third-line treatment in a patient with advanced BRAF(V600E) mutated, microsatellite-stable colon cancer: A case report and literature review
por: Piringer, Gudrun, et al.
Publicado: (2023)

Creating the “new normal” post-Coronavirus world—web-communication replacing face-to-face interaction
por: Hilbe, Wolfgang, et al.
Publicado: (2020)

Response prediction by mutation- or methylation-specific detection of ctDNA dynamics in pretreated metastatic colorectal cancer
por: Doleschal, Bernhard, et al.
Publicado: (2023)

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)
por: Huemer, Florian, et al.
Publicado: (2018)

Editorial: Current innovations in GI-oncology: Where do we stand?
por: Rumpold, Holger, et al.
Publicado: (2022)

Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study
por: Hofheinz, Ralf-Dieter, et al.
Publicado: (2022)

Circumnavigating the challenges of COVID-19 in oncology
por: Fuereder, Thorsten, et al.
Publicado: (2020)

LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study
por: Piringer, Gudrun, et al.
Publicado: (2023)

Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia
por: Kralik, Johanna M, et al.
Publicado: (2011)

Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry
por: Huemer, Florian, et al.
Publicado: (2020)

Comorbid Conditions in Patients With Metastatic Colorectal Cancer
por: Fu, Alex Z, et al.
Publicado: (2011)

Lethal human metavirus pneumonia in a patient with chronic lymphocytic leukemia
por: Rumpold, Holger
Publicado: (2021)

A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study
por: Unseld, Matthias, et al.
Publicado: (2020)

Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement
por: Taghizadeh, Hossein, et al.
Publicado: (2023)

Data of ‘Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage’
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort
por: Schlintl, Verena, et al.
Publicado: (2022)

Refeeding Syndrome in Oncology: Report of Four Cases
por: Windpessl, Martin, et al.
Publicado: (2017)

Targeting Metastatic Colorectal Cancer with Immune Oncological Therapies
por: Galbraith, Norman J., et al.
Publicado: (2021)

Shedding of the Endothelial Glycocalyx Independent of Systemic Tryptase Release during Oncologic Oral Surgery: An Observational Study
por: Drinhaus, Hendrik, et al.
Publicado: (2022)

Pathological Internet Use—An Important Comorbidity in Child and Adolescent Psychiatry: Prevalence and Correlation Patterns in a Naturalistic Sample of Adolescent Inpatients
por: Fuchs, Martin, et al.
Publicado: (2018)

Fatal Spontaneous Tumor Lysis Syndrome in a Patient with Metastatic Colon Cancer: A Clinical Case of Rare Oncological Emergency
por: Shaforostova, Inna, et al.
Publicado: (2020)

Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting
por: Sztankay, Monika, et al.
Publicado: (2017)

Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer
por: Jehn, C F, et al.
Publicado: (2012)

How to implement routine electronic patient‐reported outcome monitoring in oncology rehabilitation
por: Wintner, Lisa M., et al.
Publicado: (2020)

Metastatic disease in head & neck oncology
por: Pisani, Paolo, et al.
Publicado: (2020)

Current challenges in the implementation of precision oncology for the management of metastatic colorectal cancer
por: Kim, Sun Young, et al.
Publicado: (2020)

Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Assessment of independent comorbidities and comorbidity measures in predicting healthcare facility-onset Clostridioides difficile infection in Kenya
por: Mutai, Winnie C., et al.
Publicado: (2022)

Ruxolitinib therapy for myelofibrosis in Austria: Consensus on therapy management
por: Krauth, Maria-Theresa, et al.
Publicado: (2018)

The Effect of the Modified Lateral Suprascapular Block on Shoulder Function in Patients With Chronic Shoulder Pain
por: Dorn, Christian, et al.
Publicado: (2015)

QT prolongation predicts short-term mortality independent of comorbidity
por: Gibbs, Charlotte, et al.
Publicado: (2019)

Receptor-Independent Therapies for Forensic Detainees with Schizophrenia–Dementia Comorbidity
por: Sfera, Adonis, et al.
Publicado: (2023)

Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Zullig, Leah L., et al.
Publicado: (2022)

Brain lesions in oncology patients: recognising metastatic versus non metastatic lesions
por: Rich, Philip
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4e8356ntvioi33irj20lho2ppv